Increase in Emotional Distress Observed Worldwide in 2020

MONDAY, March 27, 2023 (HealthDay News) -- The pandemic period was characterized by an increase in emotional distress in 2020, followed by a decline in 2021, according to a study published online March 27 in the Proceedings of the National Academy of Sciences.
Michael Daly, Ph.D., from Maynooth University in Ireland, and Lucía Macchia, from City University of London, used annual representative survey data from 1.53 million individuals surveyed in 113 countries from 2009 to 2021 to examine emotional distress. Participants reported worry, sadness, stress, or anger during much of the previous day.
The researchers found that between 2009 and 2021, there was an increase from 25 to 31 percent in the prevalence of feelings of emotional distress in within-county estimates; the largest increases in distress were seen in countries with low levels of education and income. In 2020, distress rose by 2.5 percent over and above the existing prepandemic trend in distress, with significant increases observed among most demographic groups. From 2020 to 2021, distress levels decreased and did not deviate from existing time trends in distress, as estimated using prepandemic data.
"Distress levels declined from 2020 to 2021 and at this point were not greater than expected based on prepandemic trends," the authors write. "This result is consistent with findings suggesting that populations flexibly adapted to the stressful circumstances of the pandemic and recovered relatively quickly from the distressing impact of the initial lockdown period."
Related Posts
Mantenerse hidratado podría significar menos enfermedad y un envejecimiento más lento
MARTES, 3 de enero de 2023 (HealthDay News) -- ¿Podría la hidratación ser la...
Early Treatment Can Be Initiated for A-Fib Patients With Stroke
MONDAY, June 5, 2023 (HealthDay News) -- For patients with atrial fibrillation...
Rituximab Studied as Add-On Therapy for New-Onset Myasthenia Gravis
TUESDAY, Oct. 4, 2022 (HealthDay News) -- A single infusion of rituximab early...
U.S. Buys 600,000 Doses of New COVID Treatment Still Awaiting FDA Approval
FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. government has bought 600,000...
